Readout properties as a function of ensemble size <i>K</i>. by Adrien Wohrer (706872)

“…<p>(A) The SVD decomposes population activity into a number of modes <i>m</i> with decreasing powers </p><p></p><p></p><p><mi>λ</mi><mi>m</mi><mn>2</mn></p><p></p><p></p>. …”

Quantitative effect of TAS2R agonists on [Ca²⁺]_i in HASM stimulated by five GPCR agonists. by Blanca Camoretti-Mercado (762326)

Map showing study region (southern shores of Lake Victoria, Tanzania). by Roland Proud (11764892)

Effects of single gene RNAi knockdown experiments. by Michael A. Najarro (831657)

Cytisine significantly decreased sucrose intake in rats consuming sucrose short-term (4 weeks) and long-term (12 weeks) using the intermittent-access two-bottle choice paradigm. by Masroor Shariff (2583442)

“…<p>Cytisine (4 mg/kg) significantly decreased sucrose consumption (Fig 3A and 3B) after the onset of drinking in short-term (4 weeks) and long-term (12 weeks) sucrose exposure rats. …”

Mecamylamine significantly decreased sucrose intake in rats consuming sucrose short-term (4 weeks) and long-term (12 weeks) using the intermittent-access two-bottle choice paradigm... by Masroor Shariff (2583442)

“…<p>Mecamylamine (2 mg/kg) significantly decreased sucrose consumption in short-term (4 weeks) and long-term (12 weeks) sucrose exposure rats (Fig 2A and 2B). …”

Relationship between <i>G</i>_<i>max</i>, cell size, and <i>TRD</i>_<i>Gmax</i>. by Kevin J. Flynn (2615002)

“…<p>Maximum N:C (at <i>G</i> = <i>G</i>_<i>max</i>) was assumed as 0.18 gN gC^-1.The required value for <i>TRD</i>_<i>Gmax</i> in C_diat is less than that for C_prot because diatoms, being more vacuolated with a lower gC (cell L)^-1, have a decreased demand for N across a given area of cell plasma-membrane. …”

Demographic data of patients with POAG and OHT. by Chareenun Chirapapaisan (8843843)

“…In total, 28 eyes were included in the study, with a mean patient age of 65.71±10.2 years. After IOP reduction, all biometric parameters, except CCT and ACD, exhibited a decrease without reaching statistical significance (all p>0.05). …”

Increased p27Kip1 and decreased phosphorylated p27Kip1 at S10 and T198 by lowering H₂O₂ levels. by Irene L. Ibañez (137874)

Participant and lab results flow. by Gad Murenzi (6243719)

“…</p><p>Results</p><p>Women included in this analysis (N = 4,880) had a mean age of 40 years, > 98% were on antiretroviral therapy, and 61% had a CD4 count of ≥500 cells/µL. …”

Decreased numbers of <i>dicer</i>^<i>CKO</i> P14 effector cells demonstrate an intrinsic role of Dicer during CD8 T cell expansion. by Florian M. Baumann (3119772)

Illustration of the main differences in ulna morphology between running groups, based on morphometric and microarchitecture analyses. by Andy Xavier (20141395)

Raw data. by Wei Li (7081)

“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”

Best fit and the values of the parameters. by Wei Li (7081)

“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”

Base-case analysis results without or with PAP. by Wei Li (7081)

“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”

Results of scenario analyses for cCRT population. by Wei Li (7081)

“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”

Live-cell imaging reveals multiple patterns of Tax expression in naturally-infected T-cell clones. by Saumya Ramanayake (7879091)

Results of scenario analyses for sCRT population. by Wei Li (7081)

“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”

Baseline characteristics of participants. by Hyungjong Park (10147327)

“…In the multivariable Cox regression analysis, eGFR > 120 mL/min ∙ 1.73 m² was associated with a decreased risk of dyslipidemia (HR: 0.35; 95% CI [0.34–0.36]). …”

S1 Data - by Kadio Jean-Jacques Olivier Kadio (15503159)

“…The LTFU rate was 54.5 per 1000 person-months (95% CI 53.6–55.4), with the peak hazards of LTFU occurring after the first visit and decreasing steadily over time. In an adjusted analysis, the hazards of LTFU were higher among men compared to women (aHR = 1.10; 95%CI 1.08–1.12), being aged 13–25 years old versus older patients (aHR = 1.07; 95%CI = 1.03–1.13), and among those initating ART in smaller health facilities (aHR = 1.52; 95%CI 1.45–1.60). …”